ArticleHuman vaccines & immunotherapeutics2025

Off-label use of recombinant adjuvanted Herpes Zoster vaccine in a 10-year-old high-risk patient affected by epidermolysis bullosa: A case report.

Claudia Palmieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.